> Italy's Cosmo Pharmaceuticals will pick up a €2 million upfront fee after inking a global licensing deal with Ferring for a reformulated budesonide product. Cosmo also could receive up to €58 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results